However, a recent study showed no correlation between cirrhosis, hepatic decompensation, HCC, and survival during the 10-year follow up in patients with CHC with or without autoantibody positivity (including ANA, ASMA, AMA, and anti-LKM (Gilman et al., 2018). The gene discussed is BTG3; the disease is hepatocellular carcinoma.